ARTICLE | Clinical News
FDA approves Hologic's Aptima HSV 1 & 2 assay
June 22, 2017 11:31 PM UTC
FDA approved the Aptima HSV 1 & 2 assay from Hologic Inc. (NASDAQ:HOLX) to diagnose and differentiate HSV-1 and HSV-2 infection. The in vitro nucleic acid amplification test is designed to run on the...
BCIQ Company Profiles